Story · Medicine & Biotech · Health Tech
Samra Turajlić: Fully Funded MB-PhD Targets Tumour-Immune Vulnerabilities With AI
1 outlet · first reported by OncoDaily on
Samra Turajlić, Director of the Cancer Research UK Manchester Institute, Consultant Oncologist at The Christie and Professor at the University of Manchester, shared on LinkedIn: “Calling medical students at the (OncoDaily)
Coverage, in order
-
Samra Turajlić: Fully Funded MB-PhD Targets Tumour-Immune Vulnerabilities With AISamra Turajlić, Director of the Cancer Research UK Manchester Institute, Consultant Oncologist at The Christie and Professor at the University of Manchester, shared on LinkedIn: “Calling medical students at the
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.